SecSonar.com

Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sagimet Biosciences Inc. (SGMT) is a Biotechnology company based in US with a market capitalization of $235M. Free cash flow was negative at -$45.7M. This page tracks SGMT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 14 employees · IPO Jul 17, 2023

Valuation

Valuation & price

$6.90 · as of May 17, 2026 · -32.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.24$7.43$4.62Jul 25Dec 25Jul 26Jul 7, 25$8.68Jul 9, 25$9.50Jul 11, 25$9.47Jul 15, 25$9.49Jul 17, 25$9.55Jul 21, 25$8.83Jul 23, 25$9.59Jul 25, 25$10.24Jul 29, 25$9.27Jul 31, 25$8.69Aug 4, 25$8.45Aug 6, 25$9.17Aug 11, 25$8.75Aug 13, 25$9.58Aug 15, 25$7.67Aug 19, 25$6.91Aug 21, 25$7.35Aug 25, 25$7.08Aug 27, 25$7.78Aug 29, 25$7.51Sep 3, 25$7.34Sep 5, 25$7.11Sep 9, 25$6.89Sep 11, 25$7.04Sep 16, 25$6.20Sep 18, 25$6.75Sep 22, 25$6.81Sep 24, 25$7.28Sep 26, 25$7.34Sep 30, 25$6.86Oct 2, 25$7.16Oct 6, 25$7.31Oct 8, 25$7.31Oct 10, 25$7.68Oct 14, 25$7.51Oct 16, 25$7.55Oct 21, 25$7.78Oct 23, 25$7.33Oct 27, 25$8.60Oct 29, 25$8.33Oct 31, 25$8.52Nov 4, 25$7.61Nov 6, 25$7.69Nov 10, 25$8.33Nov 12, 25$8.82Nov 14, 25$7.75Nov 18, 25$7.82Nov 20, 25$7.27Nov 25, 25$6.98Nov 28, 25$7.22Dec 2, 25$6.09Dec 4, 25$6.35Dec 8, 25$6.19Dec 10, 25$6.32Dec 12, 25$6.23Dec 16, 25$6.05Dec 18, 25$5.96Dec 22, 25$6.24Dec 24, 25$6.06Dec 29, 25$5.91Jan 2, 26$5.99Jan 6, 26$5.46Jan 8, 26$5.57Jan 12, 26$6.24Jan 14, 26$6.37Jan 16, 26$6.14Jan 21, 26$6.35Jan 23, 26$6.14Jan 27, 26$6.09Jan 29, 26$5.36Feb 2, 26$6.23Feb 4, 26$6.08Feb 9, 26$5.45Feb 11, 26$5.25Feb 13, 26$5.06Feb 18, 26$5.25Feb 20, 26$5.32Feb 24, 26$5.92Feb 26, 26$5.87Mar 2, 26$5.72Mar 4, 26$5.76Mar 6, 26$5.41Mar 10, 26$5.53Mar 12, 26$5.34Mar 17, 26$5.19Mar 19, 26$4.83Mar 23, 26$4.88Mar 25, 26$4.62Mar 27, 26$4.89Mar 31, 26$5.23Apr 2, 26$5.32Apr 7, 26$5.08Apr 9, 26$5.64Apr 13, 26$5.42Apr 15, 26$6.07Apr 17, 26$6.47Apr 22, 26$6.28Apr 24, 26$5.86Apr 28, 26$8.75Apr 30, 26$8.03May 4, 26$7.90May 6, 26$8.38May 8, 26$7.71May 12, 26$7.65May 14, 26$7.37May 18, 26$6.66May 20, 26$6.65May 22, 26$7.09May 28, 26$7.27Jun 1, 26$7.19Jun 3, 26$6.86Jun 5, 26$6.76Jun 9, 26$6.52Jun 11, 26$6.43Jun 15, 26$6.47Jun 17, 26$6.53Jun 22, 26$7.10Jun 24, 26$6.93Jun 26, 26$7.06Jul 2, 26$7.53
$4.5552-week range$10.24
Loading valuation history…

Fundamentals

Key fundamentals

$235M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$45.7M

Free cash flow (USD)

-$113M

Net debt

Net cash position

3.2%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$2.0MFY 2024$0.00FY 2025$0.00
$0$0

Free cash flow by year

2019 → 2025

FY 2019$-10.6MFY 2020$-10.4MFY 2021$-21.7MFY 2022$-24.5MFY 2023$-23.8MFY 2024$-42.4MFY 2025$-45.6M
-$10.6M-$45.7M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventBoard Resignation and ElectionJun 12, 2026Filing
  • 8-K eventPerformance-Based Stock Units AwardJun 3, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventFinancial Results ReportedMay 12, 2026Filing
  • 8-K eventStock OfferingApr 28, 2026Filing
  • 8-K eventClinical Trial UpdatesApr 27, 2026Filing
  • 8-K eventClinical Trial UpdatesApr 27, 2026Filing
  • 8-K eventChief Medical Officer ChangeApr 21, 2026Filing

Questions

Frequently asked questions

What is Sagimet Biosciences Inc.'s market cap?

Sagimet Biosciences Inc. (SGMT) has a market capitalization of $235M.

What is SGMT's P/E ratio?

A meaningful P/E ratio is not available for SGMT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SGMT's price-to-book (P/B) ratio?

SGMT trades at 2.11 times book value per share.

Are insiders buying SGMT stock?

SEC Form 4 filings show no open-market insider buys at Sagimet Biosciences Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VYGR

Voyager Therapeutics, Inc.

$235.3M

QSI

Quantum-Si incorporated

$235.4M

CRBU

Caribou Biosciences, Inc.

$235.6M

OBIO

Orchestra BioMed Holdings, Inc.

$236.8M

WHWK

Whitehawk Therapeutics Inc

$232.4M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.